Chemoinformaics analysis of 4-Isopropenylcyclohexanone
Molecular Weight | 138.21 | nRot | 1 |
Heavy Atom Molecular Weight | 124.098 | nRig | 8 |
Exact Molecular Weight | 138.104 | nRing | 1 |
Solubility: LogS | -1.446 | nHRing | 0 |
Solubility: LogP | 1.685 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 9 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 25.1671 |
nHD | 0 | BPOL | 14.9129 |
QED | 0.508 |
Synth | 2.623 |
Natural Product Likeliness | 1.582 |
NR-PPAR-gamma | 0.128 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.017 |
Pgp-sub | 0.007 |
HIA | 0.004 |
CACO-2 | -4.51 |
MDCK | 0.0000225 |
BBB | 0.992 |
PPB | 0.480793 |
VDSS | 0.952 |
FU | 0.531862 |
CYP1A2-inh | 0.072 |
CYP1A2-sub | 0.781 |
CYP2c19-inh | 0.055 |
CYP2c19-sub | 0.618 |
CYP2c9-inh | 0.023 |
CYP2c9-sub | 0.745 |
CYP2d6-inh | 0.01 |
CYP2d6-sub | 0.898 |
CYP3a4-inh | 0.012 |
CYP3a4-sub | 0.256 |
CL | 7.166 |
T12 | 0.829 |
hERG | 0.027 |
Ames | 0.057 |
ROA | 0.032 |
SkinSen | 0.134 |
Carcinogencity | 0.277 |
EI | 0.965 |
Respiratory | 0.38 |
NR-Aromatase | 0.01 |
Antiviral | No |
Prediction | 0.951797 |